Your browser doesn't support javascript.
loading
Altered circadian feeding behavior and improvement of metabolic syndrome in obese Tac1-deficient mice.
Maguire, C A; León, S; Carroll, R S; Kaiser, U B; Navarro, V M.
Afiliação
  • Maguire CA; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • León S; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Carroll RS; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kaiser UB; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Navarro VM; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Int J Obes (Lond) ; 41(12): 1798-1804, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28775376
ABSTRACT

BACKGROUND:

Metabolic function is regulated by the interplay of central and peripheral factors that ultimately regulate food intake (FI) and energy expenditure. The tachykinin substance P (SP) has been identified as a novel regulator of energy balance, however, the mechanisms underlying this effect are ill-defined and conflicting data regarding the role of SP on FI have been reported by different groups.

OBJECTIVE:

To further characterize the metabolic role of the Tac1 gene products (SP and neurokinin A) in mice through a series of genetic, metabolic and behavioral studies in Tac1-deficient mice.

RESULTS:

Tac1-/- mice are leaner than controls and display reduced FI and altered feeding circadian rhythm, supported by disrupted expression of the clock genes Cry1/2, Per1/2 in the suprachiasmatic nucleus, mediobasal hypothalamus (MBH) and liver, as well as increased proopiomelanocortin expression in the MBH. Tac1 ablation induced resistance to obesity, improved glucose tolerance, prevented insulin resistance under high-fat diet, increased activation of brown adipose tissue and improved hepatic steatosis. Moreover, deletion of Tac1 in ob/ob mice ameliorated body weight gain in females only but was sufficient to decrease fat and triglyceride content in the liver of males.

CONCLUSIONS:

These results provide further evidence that Tac1 controls circadian feeding behavior and metabolism in mice through mechanisms that involve the regulation of the melanocortin system. In addition, these studies suggest that the blockade of SP may offer a new method to treat metabolic syndrome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Taquicininas / Substância P / Receptores da Neurocinina-1 / Síndrome Metabólica / Comportamento Alimentar / Antagonistas dos Receptores de Neurocinina-1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Int J Obes (Lond) Assunto da revista: METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Taquicininas / Substância P / Receptores da Neurocinina-1 / Síndrome Metabólica / Comportamento Alimentar / Antagonistas dos Receptores de Neurocinina-1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Int J Obes (Lond) Assunto da revista: METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos